Abstract
Background Schizophrenia is a severe neuropsychiatric disorder accompanied by debilitating cognitive and psychosocial impairments over the course of the disease. As disease trajectories exhibit considerable inter-individual heterogeneity, early clinical and neurobiological predictors of long-term outcome are desirable for personalized treatment and care strategies.
Methods In a naturalistic longitudinal approach, 381 schizophrenia patients from the Iowa Lon-gitudinal Study (ILS) cohort underwent an extensive characterization, including repeated magnetic resonance imaging (MRI) scans, over a mean surveillance period of 11.07 years. We explored whether pre-diagnostic markers, clinical markers at the first psychotic episode, or magnetic resonance imaging (MRI) measures at the onset of the disease were predictive of relapse or remission of specific symptom patterns later in life.
Results We identified a set of clinical parameters - namely premorbid adjustment during adolescence, symptom patterns, and neuropsychological profiles at disease onset – that were highly correlated with future disease trajectories. In general, brain measures at baseline did not correlate with outcome. Progressive regional brain volume losses over the observation period, however, were highly correlated with relapse patterns and symptom severity.
Conclusions Our findings provide clinicians with a set of highly robust, easily acquirable, and cost-effective predictors for long-term outcome in schizophrenia. These results can be directly translated to a clinical setting to improve prospective care and treatment planning for schizophrenia patients. (Funding sources: NIH MH68380, MH31593, MH40856, and MH43271).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NIH MH68380, MH31593, MH40856, and MH43271
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of the University of Iowa gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are stored at the University of Iowa.
